Signature
/s/ James C. Foster
Issuer symbol
CRL
Transactions as of
30 Jan 2026
Net transactions value
-$3,104,076
Form type
4
Filing time
02 Feb 2026, 16:46:30 UTC
Previous filing
03 Jun 2025
Next filing
04 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
FOSTER JAMES C Chairman, President and CEO, Director C/O CHARLES RIVER LABORATORIES, 251 BALLARDVALE STREET, WILMINGTON /s/ James C. Foster 02 Feb 2026 0001141722

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRL Common Stock Award $0 +39,031 +17% $0.000000 268,341 30 Jan 2026 Direct F1, F2
transaction CRL Common Stock Tax liability $3,104,076 -14,664 -5.5% $211.68 253,677 30 Jan 2026 Direct
holding CRL Common Stock 5,423 30 Jan 2026 2024 GRAT
holding CRL Common Stock 20,000 30 Jan 2026 2025 GRAT
holding CRL Common Stock 230 30 Jan 2026 by Trust
holding CRL Common Stock 750 30 Jan 2026 By Trust
holding CRL Common Stock 2,250 30 Jan 2026 By Trust
holding CRL Common Stock 10,000 30 Jan 2026 Held By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 26, 2023.
F2 Reflects the exempt transfer pursuant to Rule 16a-13 of (i) 14,577 shares from the 2024 GRAT account to direct holdings; and (ii) 4,048 shares from the 2022 GRAT account to direct holdings.